These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2760838)

  • 1. Adenosine-angiotensin II interactions. Part II. The role of adenosine in regulating angiotensin II-induced changes in heart rate and aldosterone release.
    Holycross BJ; Li P; Jackson EK
    J Pharmacol Exp Ther; 1989 Aug; 250(2):442-53. PubMed ID: 2760838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine-angiotensin II interactions. Part I. Role of adenosine in regulating angiotensin II-induced potentiation of noradrenergic neurotransmission and angiotensin II-induced vasoconstriction.
    Holycross BJ; Jackson EK
    J Pharmacol Exp Ther; 1989 Aug; 250(2):433-41. PubMed ID: 2547930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeine potentiates vasodilator-induced renin release.
    Tofovic SP; Branch KR; Oliver RD; Magee WD; Jackson EK
    J Pharmacol Exp Ther; 1991 Mar; 256(3):850-60. PubMed ID: 2005584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone.
    Brilla CG; Zhou G; Matsubara L; Weber KT
    J Mol Cell Cardiol; 1994 Jul; 26(7):809-20. PubMed ID: 7966349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary microvascular fluid flux and permeability: influence of angiotensin II, aldosterone, and acute arterial hypertension.
    Reddy HK; Campbell SE; Janicki JS; Zhou G; Weber KT
    J Lab Clin Med; 1993 Mar; 121(3):510-21. PubMed ID: 8445300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II and aldosterone receptor binding in rat heart and kidney: response to chronic angiotensin II or aldosterone administration.
    Sun Y; Weber KT
    J Lab Clin Med; 1993 Oct; 122(4):404-11. PubMed ID: 8228554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeine potentiates the renin response to furosemide in rats. Evidence for a regulatory role of endogenous adenosine.
    Paul S; Jackson EK; Robertson D; Branch RA; Biaggioni I
    J Pharmacol Exp Ther; 1989 Oct; 251(1):183-7. PubMed ID: 2677316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difference between intracarotid and intravenous infusions of angiotensin II on baroreflex sensitivity and vasopressin release in conscious rats.
    Fenoy FJ; Ubeda M; García-Estañ J; Quesada T
    Rev Esp Fisiol; 1987 Sep; 43(3):355-60. PubMed ID: 3423394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypotension in end-stage renal disease: effect of postural change, exercise and angiotensin II infusion on blood pressure and plasma concentrations of angiotensin II, aldosterone and arginine vasopressin in hypotensive patients with chronic renal failure treated by dialysis.
    Sørensen SS; Danielsen H; Jespersen B; Pedersen EB
    Clin Nephrol; 1986 Dec; 26(6):288-96. PubMed ID: 3802595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of adenosine blockade on plasma renin activity and catecholamines.
    Tung CS; Kuan CJ; Tarng JL; Tseng CJ
    Proc Natl Sci Counc Repub China B; 1993 Jan; 17(1):21-8. PubMed ID: 8234540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Participation of AT1 and AT2 receptors in the differential interaction between angiotensin II or III and alpha-2 adrenoceptors in the nucleus reticularis gigantocellularis in cardiovascular regulation and antinociception in rats.
    Yang CH; Shyr MH; Tan PP; Chan SH
    J Pharmacol Exp Ther; 1996 Nov; 279(2):795-802. PubMed ID: 8930186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in aldosterone and angiotensin II levels in salt-induced hypertension.
    Bayorh MA; Ganafa AA; Emmett N; Socci RR; Eatman D; Fridie IL
    Clin Exp Hypertens; 2005 May; 27(4):355-67. PubMed ID: 15921072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced angiotensin II induced vascular reactivity in chronic renal failure.
    Jespersen B; Pedersen EB; Christensen NJ; Danielsen H; Sørensen SS
    Scand J Clin Lab Invest; 1988 Nov; 48(7):705-13. PubMed ID: 3201105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of endogenous adenosine as a modulator of the renin response to salt restriction.
    Kuan CJ; Wells JN; Jackson EK
    Nephrologie; 1987; 8(6):283-6. PubMed ID: 3330576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance.
    Ran J; Hirano T; Fukui T; Saito K; Kageyama H; Okada K; Adachi M
    Metabolism; 2006 Apr; 55(4):478-88. PubMed ID: 16546478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre- and postjunctional effects of angiotensin II in hypertension due to adenosine receptor blockade.
    Morato M; Pinho D; Sousa T; Guimarães S; Moura D; Albino-Teixeira A
    Eur J Pharmacol; 2006 Feb; 531(1-3):209-16. PubMed ID: 16438958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of prolonged and brief infusions of noradrenaline on arterial pressure and on the plasma concentrations of active renin, angiotensin II, aldosterone and potassium.
    Casals-Stenzel J; Tree M; Brown JJ; Fraser R; Lever AF; Millar JA; Morton JJ; Robertson JI; Reid JL; Hamilton C
    J Hypertens; 1983 Jun; 1(1):27-35. PubMed ID: 6397510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Activation of the renin-angiotensin system and blood pressure variability in rats].
    Blanc J; Lambert G; Elghozi JL
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):1019-22. PubMed ID: 10989749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic effects of angiotensin II in conscious, non-ascitic cirrhotic rats.
    Fernández-Muñoz MD; Villamediana LM; Blanchart A; Caramelo C; Hernando L; López-Novoa JM
    Clin Physiol Biochem; 1988; 6(1):36-43. PubMed ID: 3282751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of adenosine A(1) receptor in angiotensin II- and norepinephrine-induced renal vasoconstriction.
    Aki Y; Nishiyama A; Miyatake A; Kimura S; Kohno M; Abe Y
    J Pharmacol Exp Ther; 2002 Oct; 303(1):117-23. PubMed ID: 12235241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.